Marcellus Investment Managers - One of the Best Portfolio Management Service Companies in India
  • Region
    India USA
  • Our Philosophy
  • Offerings

    Portfolio Management Services (PMS)


    Indian Equities
    Consistent Compounders Rising Giants Little Champs Kings of Capital MeritorQ PMS Curation Portfolio
    Global Equities
    Global Compounders PMS
    Global Equities Fund (Retail)
    Multi Asset
    Multi Asset PMS

    Asset Allocation Services


    Asset Allocation        

    Portfolio Advisory Services


    Indian Equities
    MeritorQ Advisory (Smallcase)        
    Multi Asset
    Aggressive Allocation Balanced Allocation Conservative Allocation
  • Insights

    Newsletters


    Consistent Compounders Kings Of Capital Little Champs Rising Giants Marcellus Erudite MeritorQ PMS Global Compounders

    Insights


    Recents Blogs Newsletters Portfolio Updates 3 Longs and 3 Shorts

    Videos


    Featured Webinars Client Exclusive

    Podcasts


    All MeritorQ Podcasts (English) MeritorQ Podcasts (Hindi)
    Client Exclusive Content

    Others


    Client Exclusive Content Three Longs & Three Shorts Blogs Videos Media Centre
  • Resources
    Support Resources Online Access Guide Marcellus’ Forms UPI Payment
    Disclosure document GIFT City Disclosure PMS Fees Calculator
  • Team
  • PLAN YOUR GOALS
    • Invest Now
      • Portfolio Management Services (PMS)
      • Investment Advisory Services
      • Global Equities Fund (Retail)
  • Subscribe
  • Connect
  • Login
  1. Newsletter
  2. October 2019
Oct 2019 Consistent Compounders

Consistent Compounders benefit disproportionately from tax rate cuts

Published on Oct 01, 2019 · 3 Min Read

The superficial approach of choosing winners from the recently announced tax rate cuts, is to look for companies paying the highest rate of tax and then expect a 10-15% increase in their profits. Instead, the real winners will be determined by the ability of a company to either: (a)reinvest the incremental cash flows back into the business and generate a high return on capital on this incremental capital deployed; and/or (b) increase operating expenditure via advert spends, price cuts, channel incentives, IT initiatives, HR spends, or R&D spends. Hence, firms with high ROCE and high rate of reinvestment of cash flows will be able to create a ‘snowball’ effect on their future earnings, which is yet to be factored into their share prices. Marcellus’ Consistent Compounders are the perfect fit examples of such firms. “…there has been a lot of fuzzy and often partisan commentary about who really pays corporate taxes –
businesses or their customers…. What really happens? When the corporate rate is cut, do Berkshire, The Washington Post, Cap Cities, etc., themselves soak up the benefits, or do these companies pass the benefits along to their customers in the form of lower prices? This is an important question for investors…” – Warren Buffett in Berkshire Hathaway’s 1986 Letter to shareholders Performance update – as on 30th September 2019 .We have a coverage universe of around 25 stocks, which have historically delivered a high degree of consistency in ROCE and revenue growth rates. Our research team of five analysts focuses on understanding the reasons why companies in our coverage universe have consistently delivered superior financial performance. Based on this understanding, we construct a concentrated portfolio of companies with an intended average holding period of stocks of 8-10 years or longer. The latest performance of our PMS and offshore fund (USD denominated) portfolios is shown in the charts below.

Tax rate cuts – the incorrect conclusion: higher the existing tax rates, higher the future benefits

On 20th September 2019, India’s Finance Minister announced a reduction in corporate tax rates from 30% to 22%. The knee jerk reaction to such an announcement is to find companies which incur the highest rate of tax currently and compute the increase in their profits following this announcement. Then, assuming the fair value P/E multiple of such companies remains unchanged, any increase in profits should warrant a commensurate increase in the share price of the company. As summarized in the exhibit below, using this approach, two companies with the same tax rate, but different profit margins and ROCEs, are expected to see the same appreciation in their fair values and hence share prices.

Note that the table shown above concludes that profits of the ‘Great company’ will be twice as much as the profits of the ‘Average company’, both before as well as after the cut in corporate tax rates.

We shall return to this point further on in this note.

This part of the benefit from 20th September’s announcement by the Finance Minister has already been factored into share prices over the past 10 days. However, this conclusion is superficial and incompletebecause it does not consider, the ability of a company to retain (or not retain), and then reinvest, any benefitsfrom the incremental profits retained following a cut in corporate tax payout.

On this subject, Warren Buffett stated in Berkshire Hathaway’s 1986 Letter to Shareholders (Click here) –“…there has been a lot of fuzzy and often partisan commentary about who really pays corporate taxes -businesses or their customers…. What really happens? When the corporate rate is cut, do Berkshire, The Washington Post, Cap Cities, etc., themselves soak up the benefits, or do these companies pass the benefitsalong to their customers in the form of lower prices? This is an important question for investors and managers, as well as for policymakers….

Our conclusion is that… in the price-competitive industry, whose companies typically operate with very weak business franchises. In such industries, the free market “regulates” after-tax profits in a delayed and irregular, but generally effective, manner. The marketplace, in effect, performs much the same function in dealing with the price-competitive industry as the Public Utilities Commission does in dealing with electric utilities. In these industries, therefore, tax changes eventually affect prices more than profits.

In the case of unregulated businesses blessed with strong franchises, the corporation and its shareholders are then the major beneficiaries of tax cuts. These companies benefit from a tax cut much as the electric company would if it lacked a regulator to force down prices. Many of our businesses, both those we own in whole and in part, possess such franchises. Consequently, reductions in their taxes largely end up in our pockets rather than the pockets of our customers. While this may be impolitic to state, it is impossible to deny.”

Tax rate cuts – the real impact: High ROCE + High Reinvestment rate will determine the winner

Extending the comparative analysis between a ‘Great company’ and an ‘Average company’ from exhibit 3
above, let us assume the following:

  • A Great company can deliver 50% ROCE (14% PAT margin and 3.6x capital employed turnover) with
    100% capital reinvestment rate
  • An Average company can deliver 10% ROCE (7% PAT margin and 1.4x capital employed turnover) with
    100% capital reinvestment rate

As highlighted in exhibit 4 below, the Great company will plough back the incremental profits generated from reduced tax rates, thereby creating a strong snowball effect as time progresses. Due to this ‘snowball effect’,
the ratio of incremental profits for the Great company and those for the Average company, will not remain
constant at 2x (which was apparent in the superficial analysis of Exhibit 3 above). Instead, it will widen
exponentially over time into the long-term future. This ‘snowball effect’ accelerates the earnings growth rate
of the Great company into the long term.

It is also worth noting here that a firm like HUL, which has ~100% ROCE, is unlikely to create this ‘snowball effect’ (versus a firm like Asian Paints with 40% ROCE or Pidilite with 37% ROCE) because HUL has less than 20% rate of reinvestment of cash-flows (vs 51% for Asian Paints and 68% for Pidilite) i.e. HUL has not demonstrated its ability to redeploy a large part of its operating cash flows back onto the balance sheet and then sustain its high ROCE.

In addition to the ‘snowball effect’ of reinvesting incremental profits back onto the balance sheet, some great
companies might also decide to utilise the incremental profits via increase in costs like advertisement spends,
R&D spends, IT initiatives, HR initiatives, price cuts, etc. Such actions will also benefit a ‘Great company’ more than an ‘Average company’ because of two reasons: (a) as highlighted in Exhibit 3 above, the quantum of incremental profits of a Great company are higher than those of an Average company, giving it the extra firepower to spend in these areas; (b) some of the moats of a Great company might have been built around R&D / IT / HR / brand-recall, etc – which might not be true for the Average company. At this point, it might be tempting to believe that a firm like HUL will be able to benefit from its higher profit margin, brand and distribution strength etc compared to its competitors. However, for such firms, these gains might be temporary because the next price war from a competitor like Patanjali / Nirma / Colgate / P&G will force HUL to cut its product price and hence sacrifice the incremental profits earned from the cut in corporate tax rates.

To conclude, the biggest beneficiaries of the cut in corporate tax rates are companies with a combination of high ROCE + high reinvestment rate + high tax rate. Firms which will NOT benefit much from the tax rate cut are those which either do not have avenues for capital reinvestment, or which have low pricing power (and hence will have to sacrifice the gains from the tax cut), or which have low ROCE, or those that are not cash generative. In short, the vast majority of the Indian stockmarket will not benefit from the recent cut in corporate tax rates! Those gains shall, rightfully, go to their consumers as Warren Buffett points in the quote cited earlier on in this note.

Consistent Compounders benefit disproportionately from the cut in corporate tax rates

As highlighted in exhibit 5 below, the 13 stocks in our Consistent Compounders Portfolio (CCP) will not only benefit from high existing tax rates (an effect which has been factored into their share price in September already), but also from accelerated earnings growth given their high ROCEs and capital reinvestment rates (a snowball effect which has not yet been factored into their share price).

Changes made to the Consistent Compounders PMS portfolio

In September, we added one stock to the portfolios of our clients (no stock was exited though) – Abbott India Ltd. Abbott India has delivered an excellent historical financial performance track record with industry-beating revenues, EBITDA and net earnings CAGR of 18%, 23% and 22% respectively over the last 10 years. Abbott India has consistently generated high ROCEs, averaging 39% (pre-tax) and ROICs (averaging 94% pre-tax) over the last 10 years. The firm benefits from a strong focus on India by its MNC parent firm Abbott Laboratories, which is reflected in terms of new product introductions, rigorous oversight on product/manufacturing quality and support in the implementation of global best practices across all key functions. All top ten revenue contributing brands of Abbott India rank either as #1 or #2 in their respective application areas – for instance Thyronorm (treating Thyroid), Duphaston (infertility/miscarriages), Vertin (Vertigo), etc.

Abbott India has an opportunity to grow faster than Indian pharma industry on the back of: (i) presence in under-penetrated therapy areas like thyroid, gynaecology, vaccines, etc; (ii) market share gains in core products as well as introduction of new products for treating adjacencies within the broader therapy areas. Abbott India is exceptionally strong in product efficacy, sales and marketing. The company’s earnings have historically demonstrated strong resilience to price control measures – for instance, reduction in Thyronorm prices in FY14 led to an increase its market shares/volumes and the ensuing operating leverage helped mitigate the adverse impact on margins. There exists an opportunity for margin expansion on the back of rising share of own brand contribution (currently Abbott India generates ~30-35% revenues from distribution of Novo-Nordisk Insulins where the distribution margin is low). Miles White, the Chairman and CEO of Abbott Laboratories has had a strong track record of capital allocation which – as explained in this note – is particularly important for a high cash generative firm like Abbott India which currently holds Rs 17 billion of surplus cash on its balance sheet.
Regards
Team Marcellus
If you want to read our other published material, please visit https://marcellus.in/blog/

Note: the above material is neither investment research, nor investment advice. Marcellus does not seek payment for or business from this email in any shape or form. Marcellus Investment Managers is regulated by the Securities and Exchange Board of India as a provider of Portfolio Management Services and as an Investment Advisor.

Copyright © 2018 Marcellus Investment Managers Pvt Ltd, All rights reserved.

This communication is confidential and privileged and is directed to and for the use of the addressee only. The recipient if not the addressee should not use this message if erroneously received, and access and use of this e-mail in any manner by anyone other than the addressee is unauthorised. If you are not the intended recipient, please notify the sender by return email and immediately destroy all copies of this message and any attachments and delete it from your computer system, permanently. Any opinions or advice contained in this email are subject to the terms and conditions expressed in a duly executed contract or written agreement between Marcellus Investment Managers Private Limited and the intended recipient. No liability whatsoever is assumed by the sender as a result of the recipient or any other person relying upon the opinion unless otherwise agreed in writing. The recipient acknowledges that Marcellus Investment Managers Private Limited may be unable to exercise control or ensure or guarantee the integrity of the text of the email message and the text is not warranted as to its completeness and accuracy.

Disclaimer:

Copyright © 2026 Marcellus Investment Managers Pvt Ltd, All rights reserved

Note: the above material is neither investment research, nor investment advice. Marcellus does not seek payment for or business from this material/email in any shape or form. Marcellus Investment Managers Private Limited (“Marcellus”) is regulated by the Securities and Exchange Board of India (“SEBI”) as a provider of Portfolio Management Services. Marcellus is also a US Securities & Exchange Commission (“US SEC”) registered Investment Advisor. No content of this publication including the performance related information is verified by SEBI or US SEC. If any recipient or reader of this material is based outside India and USA, please note that Marcellus may not be regulated in such jurisdiction and this material is not a solicitation to use Marcellus’s services. This communication is confidential and privileged and is directed to and for the use of the addressee only. The recipient, if not the addressee, should not use this material if erroneously received, and access and use of this material in any manner by anyone other than the addressee is unauthorized. If you are not the intended recipient, please notify the sender by return email and immediately destroy all copies of this message and any attachments and delete it from your computer system, permanently. No liability whatsoever is assumed by Marcellus as a result of the recipient or any other person relying upon the opinion unless otherwise agreed in writing. The recipient acknowledges that Marcellus may be unable to exercise control or ensure or guarantee the integrity of the text of the material/email message and the text is not warranted as to its completeness and accuracy. The material, names and branding of the investment style do not provide any impression or a claim that these products/strategies achieve the respective objectives. Further, past performance is not indicative of future results. Marcellus and/or its associates, the authors of this material (including their relatives) may have financial interest by way of investments in the companies covered in this material. Marcellus does not receive compensation from the companies for their coverage in this material. Marcellus does not provide any market making service to any company covered in this material. In the past 12 months, Marcellus and its associates have never i) managed or co-managed any public offering of securities; ii) have not offered investment banking or merchant banking or brokerage services; or iii) have received any compensation or other benefits from the company or third party in connection with this coverage. Authors of this material have never served the companies in a capacity of a director, officer or an employee.

This material may contain confidential or proprietary information and user shall take prior written consent from Marcellus before any reproduction in any form.

Regards, Team Marcellus

If you want to read our other published material, please visit https://marcellus.in/pms-investment-blog/


Copyright © 2026 Marcellus Investment Managers Pvt Ltd, All rights reserved


RELATED NEWSLETTERS

  • Aug 12, 2026

    Marcellus Portfolio Updates & Insights – August 2026

    READ MORE
  • Aug 06, 2026

    Global Compounders: Why have we underperformed the S&P500 in 2026?

    READ MORE
  • Jul 27, 2026

    Isaac Newton and the Madness of Men

    READ MORE

RELATED NEWSLETTERS

  • Aug 12, 2026

    Marcellus Portfolio Updates & Insights – August 2026

    READ MORE READ MORE
  • Aug 06, 2026

    Global Compounders: Why have we underperformed the S&P500 in 2026?

    READ MORE READ MORE
  • Jul 27, 2026

    Isaac Newton and the Madness of Men

    READ MORE READ MORE
PREV ISSUE

Why consistent compounders outperform during market stress?


Published on Sep 01, 2019
NEXT ISSUE

Introducing Little Champs – our small cap PMS


Published on Oct 18, 2019

Did`t receive OTP? 00:00 Resend
Did`t receive OTP? 00:00 Resend
Be the First to Know

Marcellus logo

At Marcellus, our Purpose is to make wealth creation simple and accessible by being trustworthy and transparent capital allocators.

  • Twitter-Marcellus Investment
  • LinkedIn-Marcellus Investment

Marcellus Investment Managers Private Limited

Please reach out to us at

Board Line : 0806-9199-400

Sales Desk: 0806-9199-401

e-mail: invest@marcellus.in


Marcellus Investment Managers
102, First Floor, Boston House, Suren Road,
Near 'Western Express Highway' Metro Station,
Andheri East, Mumbai 400093

Please reach out to us at

e-mail: help.gift@marcellus.in


Marcellus Investment Managers
IFSC Branch – Unit no. 431 and 432, Signature Building, Fourth Floor, Block 13B, Zone-1, GIFT SEZ, GIFT City, Gandhinagar – 382 355/382 050

  • Home
  • Our Team
  • Invest with us
  • GIFT City Corporate Disclosures
  • Marketing Disclosure
  • Investing Books
  • FAQs
  • Videos
  • Newsletters
  • Corporate Regulatory Disclosure
  • Company Information
  • Terms & Conditions
  • Privacy Policy
  • Responsible Investing
  • Contact Us

2026 © | All rights reserved.

Privacy Policy | Terms and Conditions

Please read the following carefully and select your residency jurisdiction


If accessing this website by giving false declaration, the person shall be solely liable/responsible for any adverse consequences suffered, legally as well as financially, pursuant to use of any information contained in this website

Beware of fraudulent websites and applications!

Marcellus or its employees will never ask you to join WhatsApp groups or social media accounts created by or on behalf of Marcellus. Marcellus does not have any App facilitating trading in securities, nor does Marcellus issue any advertisement for investment in any specific stocks or for any cash transactions.

If you come across any such activity, please report to the appropriate law enforcement authorities, and inform us on compliance@marcellus.in.

Click here for the list of our official social media handles.

Close